Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run

TheMotleyFool

0 0

Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run

On Dec. 4, 2025, Ryan Savitz, CFO CBO of Dianthus Therapeutics (NASDAQ:DNTH), exercised 20,000 stock options and immediately sold the resulting shares for a total consideration of $903,600, according to an SEC Form 4 filing.

Transaction value based on SEC Form 4 weighted average purchase price ($45.18); post-Transaction value was $0 as no direct shares remained post-sale.

* 1-year price change calculated using Dec. 4, 2025 as the reference date.

Source Fool.com

Like: 0

DNTH

Share